AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of therapeutics for age-related degenerative diseases in the United Stated. The company is developing AGEX-BAT1 and AGEX-VASC1, which are cell-based approaches in the preclinical stage of development to correct metabolic imbalances in aging; and to restore vascular support in ischemic tissues. It is also involved in the development of AGEX-iTR1547, a drug-based formulation in preclinical development for restoring regenerative potential in various aged tissues afflicted with degenerative diseases. In addition, the company develops Renelon, a first-generation tissue regeneration product designed to promote scarless tissue repair. Further, it markets genomic interpretation algorithms; and Cytiva, including pluripotent stem cell derived heart muscle cells used in screening drugs for efficacy and safety. The company was founded in 2017 and is based in Alameda, California. AgeX Therapeutics, Inc.(AMEX:AGE) operates independently of BioTime, Inc. as of November 28, 2018.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone510-671-8370
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.40 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date4/6/2020 (Estimated)
OptionableNot Optionable
AgeX Therapeutics (NYSE:AGE) Frequently Asked Questions
What is AgeX Therapeutics' stock symbol?
AgeX Therapeutics trades on the New York Stock Exchange (NYSE) under the ticker symbol "AGE."
How were AgeX Therapeutics' earnings last quarter?
AgeX Therapeutics (NYSE:AGE) issued its quarterly earnings data on Thursday, November, 14th. The company reported ($0.09) earnings per share for the quarter. The firm had revenue of $0.41 million for the quarter. AgeX Therapeutics had a negative return on equity of 165.04% and a negative net margin of 846.45%. View AgeX Therapeutics' Earnings History.
When is AgeX Therapeutics' next earnings date?
Has AgeX Therapeutics been receiving favorable news coverage?
Media coverage about AGE stock has been trending somewhat positive on Friday, InfoTrie reports. The research group ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. AgeX Therapeutics earned a news sentiment score of 0.7 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for AgeX Therapeutics.
Who are some of AgeX Therapeutics' key competitors?
Some companies that are related to AgeX Therapeutics include Kamada (KMDA), Sol Gel Technologies (SLGL), Osmotica Pharmaceuticals (OSMT), BIOFRONTERA AG/ADR (BFRA), Concert Pharmaceuticals (CNCE), Neptune Wellness Solutions (NEPT), Hookipa Pharma (HOOK), MEI Pharma (MEIP), Syndax Pharmaceuticals (SNDX), Theratechnologies (THERF), Seres Therapeutics (MCRB), Affimed (AFMD), Cerecor (CERC), Aeglea Bio Therapeutics (AGLE) and Advanz Pharma (CXRXF).
What other stocks do shareholders of AgeX Therapeutics own?
Who are AgeX Therapeutics' key executives?
AgeX Therapeutics' management team includes the folowing people:
- Mr. Alfred D. Kingsley, Exec. Chairman (Age 75)
- Dr. Michael D. West, Pres, CEO & Director (Age 65)
- Mr. Russell L. Skibsted, Chief Financial Officer (Age 59)
- Mr. Nafees Naseer Malik, Chief Operating Officer
- Dr. Aubrey D. N. J. de Grey BA, MA,Ph.D., Vice-Pres of New Technology Discovery
How do I buy shares of AgeX Therapeutics?
Shares of AGE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is AgeX Therapeutics' stock price today?
One share of AGE stock can currently be purchased for approximately $1.85.
How big of a company is AgeX Therapeutics?
What is AgeX Therapeutics' official website?
How can I contact AgeX Therapeutics?
AgeX Therapeutics' mailing address is 965 ATLANTIC AVENUE SUITE 101, ALAMEDA CA, 94501. The company can be reached via phone at 510-671-8370.
MarketBeat Community Rating for AgeX Therapeutics (NYSE AGE)
MarketBeat's community ratings are surveys of what our community members think about AgeX Therapeutics and other stocks. Vote "Outperform" if you believe AGE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AGE will underperform the S&P 500 over the long term. You may vote once every thirty days.
